Liver Cancer Surgery Cost Calculator

Liver Cancer Surgery Cost Calculator helps estimate Korea-related cancer surgery, cancer drug, reimbursement, and treatment reserve scenarios in English.

Health cost scenario inputs

Enter Korea-related chronic care, eldercare, therapy, procedure, fertility, diagnostic, or medical tourism assumptions. Results are simplified planning estimates.

Treatment gross quote

₩20,000,000

Insurance or support amount

₩8,000,000

Estimated self-pay with reserve

₩16,200,000

Monthly reserve target

₩1,350,000

12 month plan

This English page is a simplified Korea-related health, eldercare, therapy, chronic disease, fertility, non-covered care, or medical tourism planning estimate. It is not medical advice and does not replace diagnosis, treatment decisions, insurer review, hospital quotes, or government benefit decisions.

Related calculators

Liver cancer (HCC) surgery and TACE cost calculator

This English page follows the Korean hepatocellular carcinoma cost guide for liver resection (open or laparoscopic), robotic liver resection, transarterial chemoembolization (TACE), radiofrequency ablation (RFA), liver transplant, and systemic therapy, keeping the same pure calculation model for treatment type, Child-Pugh liver function, resection extent, TACE session count, cancer special-case copay, room, caregiver, private indemnity, and tax credit.

Treatment options and covered fees

Laparoscopic or open liver resection uses KRW 9,000,000 as the covered base fee, with a KRW 2,000,000 covered add-on for major resection (right hepatectomy or three or more segments). Robotic liver resection charges the robot surgery fee entirely out of pocket (KRW 6,000,000 to KRW 13,000,000, with KRW 10,000,000 as the average), while the covered surgery base is zero.

TACE (transarterial chemoembolization) is a covered procedure at about KRW 2,000,000 per session, and because hepatocellular carcinoma recurs often it is usually repeated 2 to 4 times or more, so the calculator multiplies the per-session fee by the number of sessions. RFA (radiofrequency ablation) is covered at about KRW 4,000,000 for small tumors 3 cm or under. Liver transplant is a very high covered total (about KRW 60,000,000) with a long stay and lifelong immunosuppressants.

  • TACE is billed per session and repeated; ward and caregiver cost also accrue per session.
  • Major liver resection adds KRW 2,000,000 as a covered add-on.
  • Systemic therapy (atezolizumab plus bevacizumab first line, covered since May 2022) is outpatient; high drug cost is covered separately.
  • Covered ward fee is KRW 100,000 per inpatient day.

Cancer special-case copay and Child-Pugh

Ordinary inpatient treatment uses a 20 percent NHI copay. Liver cancer special-case registration (V193) reduces the covered copay to 5 percent for 5 years, but it never applies to the non-covered robotic surgery fee or upper-grade room charges.

Because hepatocellular carcinoma usually arises with cirrhosis, Child-Pugh liver function (A, B, C) drives the treatment choice: A allows resection or transplant, B limits major resection, and C prioritizes transplant. The Child-Pugh input is informational and does not change the fee.

How to read the result

The estimate separates covered procedure fee, covered ward fee, robotic fee, room surcharge, pain-control injection, caregiver cost, private indemnity reimbursement, and the Korean medical expense tax credit (3 percent of salary threshold, 15 percent credit rate, with no 7,000,000 won cap for cancer patients).

This is a cost-planning estimate based on 2026 Korean rules, not medical advice. Tumor number, size, location, liver function, transplant donor availability, complications, and hospital quotes can change the final bill. The annual copay ceiling (about KRW 900,000 to KRW 8,430,000 by income in 2026) can refund excess covered copay.